Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Benefits Of Grapefruit

FDA Appointed Arthritis Advisory Committee Recommends U.S. Food And Drug Administration Approval For KRYSTEXXA(TM) For Refractory Chronic Gout
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of 14 to 1 that KRYSTEXXA(TM) (pegloticase), a biologic PEGylated uricase enzyme, be granted marketing approval by the FDA for the treatment of refractory chronic gout. Refractory chronic gout or treatment failure gout (TFG) is gout in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with conventional urate-lowering therapy at the maximum medically appropriate dose or for whom conventional urate-lowering therapy is contraindicated. The current target Prescription Drug User Fee (PDUFA) action date for the FDA"s decision as to whether to grant marketing approval for KRYSTEXXA is August 1, 2009.
generic viagra online
ZyGEM Releases Data Confirming Its PrepGEM(R) Bacteria Kit Is A Simple, Universal Method For Extracting DNA From Different Bacteria Species
ZyGEM Corp. Ltd., a provider of innovative enzyme-based products for DNA extraction and other life sciences applications, today announced the availability of a new application note documenting that its prepGEM(R) Bacteria DNA extraction kit is capable of producing high quality, ready-to-analyze DNA from a broad range of bacterial species, including mixed or unknown sample types. This addresses an important unmet need --current DNA extraction methods typically require the use of different enzymes for each type of bacteria tested. The prepGEM(R) Bacteria kit also uses a single closed-tube system that reduces extraction time and cost while protecting the sample from contamination and making the kit easily adaptable for automation.
News of the day
Kidney Atlas In 3-D Created For Researchers And Physicians
Renal diseases shall be diagnosed earlier and treated more successfully in the future. Towards this aim, researchers from nine European countries*, coordinated by the Max DelbrÃøck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have been working for the past four-and-a half years to create a three-dimensional virtual "Kidney Atlas". It incorporates the latest research findings on the development and diseases of the kidney. The Kidney Atlas was part of the European Renal Genome Project (EuReGene), which the European Union (EU) funded with more than 10 million euros. At the conclusion of the project, the Kidney Atlas was presented at MDC during a two-day symposium from May 15-16, 2009, which was attended by approximately 100 researchers.
Cardiovascular

5-to-3 Majority Supports The Idea Of A Public Or Government Health Plan To Compete With Private Insurance

One of the hotly contested issues in the debate about health care reform is whether or not there should be a new government health plan to compete with the plans offered by the insurance industry to employers and individuals. This idea is strongly supported by President Obama and most Democratic members of Congress but Republican members of Congress unanimously oppose it. Other polls have shown that attitudes to this proposal vary depending on the language used to describe it. Supporters are now calling it a "public option." Opponents usually call it a "government-run" plan. A new Harris Poll tries to bridge this language gap by asking the public about the proposal of a new "public, or government-sponsored, health plan." This poll finds that a modest 52% to 30% majority supports such a plan, and that the arguments in favor of it tend to generate more support than those against it. These are some of the results of The Harris Poll® of 2,276 U.S. adults surveyed online by Harris Interactive® between July 9 and 13, 2009. In addition to the 5-to-3 majority support of the plan, the survey tested the strengths of three arguments in favor of a public, or government plan and three against it. The three arguments in favor elicited the support of majorities between 68% and 55%: - A 68% majority thought a public plan would be a valuable alternative to private insurance; - A 63% majority thought that it would help to keep insurance costs down; and - A 55% majority thought it would help patients to get better care. Arguments against a public plan generated mixed reactions: - A 55% majority agreed it would reduce the freedom of patients to choose the doctors and treatments they want, but - A 54% majority disagreed that it would be "too much like socialism," and - A 56% majority disagreed that it would drive insurance companies out of business. So What? Given that health care reform is being so hotly debated and is getting a great deal of media coverage, attitudes to this proposal for a public plan are likely to change. Furthermore, it is always possible that it may change, or even be dropped, as part of a compromise to achieve a bill that can be passed with a few Republican votes in Congress. However, the 5-to-3 majority of the public in favor of a public plan suggests that it has the potential to help persuade some members of the public to support bills proposed by the Congress that include it. Methodology The Harris Poll® was conducted online within the United States July 9 and 13, 2009, among 2,276 adults (aged 18 and over). Figures for age, sex, race/ethnicity, education, region and household income were weighted where necessary to bring them into line with their actual proportions in the population. Propensity score weighting was also used to adjust for respondents" propensity to be online. Full data tables and methodology are available at http://www.harrisinteractive.com. Harris Interactive


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009